IDENTIFYING GENETIC, TRANSCRIPTIONAL, AND MICROENVIRONMENT DRIVERS OF LETHAL PROSTATE CANCER FOR PATIENT STRATIFICATION, DISEASE TRACKING, AND DRUG TARGET DISCOVERY.
$824,895FY2021Defense Health AgencyDOD
University Of Melbourne, Melbourne
University Of Melbourne, Melbourne